Britannia Life Sciences Inc. (CSE: BLAB)
Canada
· Delayed Price · Currency is CAD
0.0800
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
Britannia Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Mar '24 Mar 30, 2024 | Mar '23 Mar 30, 2023 | Mar '22 Mar 30, 2022 | Mar '21 Mar 30, 2021 | Mar '20 Mar 30, 2020 |
Cash & Equivalents | 0.98 | 1.32 | 2.6 | 1.63 | 0.83 | 0.14 |
Cash & Short-Term Investments | 0.98 | 1.32 | 2.6 | 1.63 | 0.83 | 0.14 |
Cash Growth | -61.23% | -49.10% | 59.29% | 96.92% | 487.90% | - |
Receivables | 1.68 | 1.21 | 1.6 | 1.79 | 1.69 | 0.02 |
Inventory | 0.19 | 0.18 | - | - | - | - |
Prepaid Expenses | 0.03 | 0.01 | 0.02 | 0.06 | - | - |
Total Current Assets | 2.87 | 2.73 | 4.22 | 3.48 | 2.51 | 0.16 |
Property, Plant & Equipment | 0.66 | 0.72 | 0.45 | 0.55 | 0.7 | - |
Long-Term Investments | - | 0.73 | 1.27 | 0 | - | - |
Goodwill | 18.79 | 17.78 | 17.38 | 17.06 | 18.23 | - |
Other Intangible Assets | 0.43 | 0.3 | 0.23 | 0 | 0 | - |
Total Assets | 22.76 | 22.26 | 23.55 | 21.09 | 21.45 | 0.16 |
Accounts Payable | 2.77 | 2.39 | 2.26 | 2.96 | 2.03 | 0.15 |
Accrued Expenses | 0.73 | 0.61 | 0.3 | 0.42 | 0.16 | - |
Short-Term Debt | 0.03 | 0.15 | 0.12 | 4.89 | 7.95 | - |
Current Portion of Long-Term Debt | 2.25 | 1.97 | 1.87 | - | - | - |
Current Portion of Leases | 0.11 | 0.11 | 0.06 | 0.05 | 0.04 | - |
Other Current Liabilities | 5.57 | 5.27 | - | - | - | - |
Total Current Liabilities | 11.46 | 10.5 | 4.6 | 8.32 | 10.19 | 0.15 |
Long-Term Debt | 4.78 | 4.76 | 6.29 | 0.12 | 2.36 | - |
Long-Term Leases | 0.26 | 0.3 | 0.08 | 0.13 | 0.19 | - |
Long-Term Deferred Tax Liabilities | 0.03 | 0.03 | 0.1 | 0.08 | 0.09 | - |
Other Long-Term Liabilities | -0 | - | 1.42 | 6.95 | 5.96 | - |
Total Liabilities | 16.54 | 15.59 | 12.49 | 15.61 | 18.79 | 0.15 |
Common Stock | 17.11 | 17.11 | 17.11 | 17.07 | 0.44 | 0.44 |
Additional Paid-In Capital | 3.41 | 3.41 | 0.16 | 0.16 | 0.16 | 0.16 |
Retained Earnings | -19.3 | -17.36 | -11.94 | -16.2 | -0.74 | -0.58 |
Comprehensive Income & Other | 0.3 | -0.72 | 1.7 | 0.32 | -0.06 | -0.01 |
Total Common Equity | 1.52 | 2.44 | 7.02 | 1.35 | -0.2 | 0 |
Minority Interest | 4.7 | 4.23 | 4.04 | 4.13 | 2.86 | - |
Shareholders' Equity | 6.22 | 6.67 | 11.06 | 5.48 | 2.66 | 0 |
Total Liabilities & Equity | 22.76 | 22.26 | 23.55 | 21.09 | 21.45 | 0.16 |
Total Debt | 7.43 | 7.29 | 8.41 | 5.19 | 10.55 | - |
Net Cash (Debt) | -6.45 | -5.96 | -5.81 | -3.56 | -9.72 | 0.14 |
Net Cash Per Share | -0.04 | -0.04 | -0.04 | -0.03 | -0.13 | 0.02 |
Filing Date Shares Outstanding | 162.25 | 162.25 | 162.25 | 161.9 | 6.47 | 6.27 |
Total Common Shares Outstanding | 162.25 | 162.25 | 162.25 | 161.9 | 6.47 | 6.27 |
Working Capital | -8.59 | -7.77 | -0.38 | -4.84 | -7.67 | 0 |
Book Value Per Share | 0.01 | 0.02 | 0.04 | 0.01 | -0.03 | 0.00 |
Tangible Book Value | -17.7 | -15.64 | -10.58 | -15.71 | -18.44 | 0 |
Tangible Book Value Per Share | -0.11 | -0.10 | -0.07 | -0.10 | -2.85 | 0.00 |
Machinery | 0.83 | 0.78 | 0.63 | 0.56 | 0.52 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.